X4 Pharmaceuticals Inc (NASDAQ:XFOR) traded at $0.74 at close of the session on Tuesday, December 17 and made an upward move of 14.53% on its previous day’s price.
Looking at the stock we see that its previous close was $0.64 and the beta (5Y monthly) reads 0.388 with the day’s price range being $0.66 – $0.7548. In terms of its 52-week price range, XFOR has a high of $1.60 and a low of $0.26. The company’s stock has gained about 83.07% over that past 30 days.
X4 Pharmaceuticals Inc has a market cap of $125.98 million and is expected to release its quarterly earnings report in January.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 1.02M, with a low of 700k and a high of 1.6M.
On the other hand, looking at the outlook for the XFOR stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the X4 Pharmaceuticals Inc (XFOR) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 56.95% off its SMA20 and 48.85% from its 50-day simple moving average. The RSI (14) is pointing at 64.92 while the volatility over the past week is 29.27% and jumps to 16.83% over the past one month. The beta value is 0.32, while the average true range (ATR) is currently pointing at 0.10. The average price target for the stock over the next 12 months is $3, with the estimates having a low of $3 and a high of $5. These price ends are -305.41% and -575.68% off the current price level respectively, although investors could be excited at the prospect of a -305.41% if the XFOR share price touches on the median price of $3.
Coming back to X4 Pharmaceuticals Inc (NASDAQ:XFOR), we note that the average 3-month trading volume was 3.04 million, while that of the preceding 10-day period stands at 4.75 million. Current shares outstanding are 168.51 million.
The insiders hold 30.90% of the company’s shares while institutions hold 35.58%. The data shows that short shares as of 2024-10-31, stood at 11.42 million at a short ratio of 8.64. This represents a 684.00 short interest in shares outstanding on 2024-10-31. Shares short fall in October from the previous month at 13.56 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -11.90% down in year-to-date price movement.
